Skip to main content
BrainCited
Figure 3

الوصف

Pharmacokinetic profiles of bacoside absorption and brain distribution are plotted, informing optimal dosing strategies for Bacopa monnieri supplementation in neurodegenerative conditions.

More Figures from This Paper

Bacopa monnieri's anti-amyloid and anti-tau activities in experimental models are quantified, suggesting potential disease-modifying effects beyond symptomatic cognitive improvement.

Figure 2

Bacopa monnieri's anti-amyloid and anti-tau activities in experimental models are quantified, suggesting potential disease-modifying effects beyond symptomatic cognitive improvement.

chart
Neuroprotective mechanisms of Bacopa monnieri extract are diagrammed, showing how bacosides modulate cholinergic, serotonergic, and antioxidant pathways relevant to Alzheimer's disease.

Figure 4

Neuroprotective mechanisms of Bacopa monnieri extract are diagrammed, showing how bacosides modulate cholinergic, serotonergic, and antioxidant pathways relevant to Alzheimer's disease.

diagram
Chemical structures of key bioactive bacosides isolated from Bacopa monnieri are presented, identifying the saponin compounds responsible for the plant's cognitive-enhancing properties.

Figure 5

Chemical structures of key bioactive bacosides isolated from Bacopa monnieri are presented, identifying the saponin compounds responsible for the plant's cognitive-enhancing properties.

diagram
Preclinical evidence for Bacopa monnieri's effects on memory and learning is summarized across animal models, showing improvements in spatial navigation and passive avoidance tasks.

Figure 6

Preclinical evidence for Bacopa monnieri's effects on memory and learning is summarized across animal models, showing improvements in spatial navigation and passive avoidance tasks.

chart

Figure 3

Chart
672 × 377px · 84,8 ك.ب

Source Paper

Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical …

Drug target insights (2019)

PMID: 31391778

DOI: 10.1177/1177392819866412

Cite This Figure

![Figure 3: Pharmacokinetic profiles of bacoside absorption and brain distribution are plotted, informing optimal dosing strategies for Bacopa monnieri supplementation in neurodegenerative conditions.](https://pdfs.citedhealth.com/figures/31391778/269.png)

> Source: Aimi Syamima Abdul Manap et al. "Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Pr." *Drug target insights*, 2019. PMID: [31391778](https://pubmed.ncbi.nlm.nih.gov/31391778/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/31391778/269.png" alt="Pharmacokinetic profiles of bacoside absorption and brain distribution are plotted, informing optimal dosing strategies for Bacopa monnieri supplementation in neurodegenerative conditions." />
  <figcaption>Figure 3. Pharmacokinetic profiles of bacoside absorption and brain distribution are plotted, informing optimal dosing strategies for Bacopa monnieri supplementation in neurodegenerative conditions.<br>  Source: Aimi Syamima Abdul Manap et al. "Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Pr." <em>Drug target insights</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31391778/">31391778</a></figcaption>
</figure>

أدلة ذات صلة

A
Bacopa monnieri لـ Memory Loss

التقييم A · 22 دراسات

 B
Bacopa monnieri لـ Age-Related Cognitive Decline

التقييم B · 15 دراسات